Evidence map›Paper›PMID 29874044›Full record

ArticleAnalytical chemistry2018

Rosetta Protein Structure Prediction from Hydroxyl Radical Protein Footprinting Mass Spectrometry Data.

Melanie L Aprahamian, Emily E Chea, Lisa M Jones, Steffen Lindert

Abstract read
In one paragraph

Article in Analytical chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Recent Advances in NMR Protein Structure Prediction with ROSETTA.International journal of molecular sciences · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Protein Structure Prediction with Mass Spectrometry Data.Annual review of physical chemistry · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Melanie L AprahamianDepartment of Chemistry and Biochemistry , Ohio State University , Columbus , Ohio 43210 , United States.
Emily E CheaDepartment of Pharmaceutical Sciences , University of Maryland , Baltimore , Maryland 21201 , United States.
Lisa M JonesDepartment of Pharmaceutical Sciences , University of Maryland , Baltimore , Maryland 21201 , United States.ORCID 0000-0001-8825-060X
Steffen LindertDepartment of Chemistry and Biochemistry , Ohio State University , Columbus , Ohio 43210 , United States.ORCID 0000-0002-3976-3473

Funding

Molecular models to characterize actions of calcium sensitizing drugsR01HL137015 · NHLBI · OHIO STATE UNIVERSITY · PI LINDERT, STEFFEN · 2018 to 2022
$1.8M
Rational Drug Design for Chronic Neuronal DamageR03AG054904 · NIA · OHIO STATE UNIVERSITY · PI LINDERT, STEFFEN · 2017 to 2018
$155k
NHLBI NIH HHS R01 HL137015NIA NIH HHS R03 AG054904
6 · The paper itself

Abstract

In recent years mass spectrometry-based covalent labeling techniques such as hydroxyl radical footprinting (HRF) have emerged as valuable structural biology techniques, yielding information on protein tertiary structure. These data, however, are not sufficient to predict protein structure unambiguously, as they provide information only on the relative solvent exposure of certain residues. Despite some recent advances, no software currently exists that can utilize covalent labeling mass spectrometry data to predict protein tertiary structure. We have developed the first such tool, which incorporates mass spectrometry derived protection factors from HRF labeling as a new centroid score term for the Rosetta scoring function to improve the prediction of protein tertiary structures. We tested our method on a set of four soluble benchmark proteins with known crystal structures and either published HRF experimental results or internally acquired data. Using the HRF labeling data, we rescored large decoy sets of structures predicted with Rosetta for each of the four benchmark proteins. As a result, the model quality improved for all benchmark proteins as compared to when scored with Rosetta alone. For two of the four proteins we were even able to identify atomic resolution models with the addition of HRF data.

Indexed as

Protein FootprintingCalmodulinCrystallography, X-RayCytochromes cHumansHydroxyl RadicalMass SpectrometryModels, MolecularMuramidaseMyoglobinProtein FoldingProtein Structure, TertiaryCalmodulinCytochromes cHydroxyl RadicalMuramidaseMyoglobin

Identifiers

PMID29874044
PMCPMC6008241

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.